Author:
Vidal Adriana C.,Howard Lauren E.,de Hoedt Amanda,Cooperberg Matthew R.,Kane Christopher J.,Aronson William J.,Terris Martha K.,Amling Christopher L.,Taioli Emanuela,Fowke Jay H.,Freedland Stephen J.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate cancer. N Engl J Med 349:366–381
2. Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ (2015) Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study. Clin Cancer Res 21:756–762
3. Liu Y, Chen JQ, Xie L, Wang J, Li T, He Y et al (2014) Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis. BMC Med 12:55
4. Moreira DM, Nickel JC, Gerber L, Muller RL, Andriole GL, Castro-Santamaria R et al (2014) Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer 120:190–196
5. Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM (2013) Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. APJCP 14:243–248
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献